UC San Diego Health Recognized for Health Equity in Care of Sickle Cell Crisis

The CAPH award was achieved with the leadership of Chad VanDenBerg, MPH, chief quality and patient safety officer, Srila Gopal, MBBS, medical director of the adult sickle cell program, and the entire team at UC San Diego Health.

UC San Diego Health has been awarded the prestigious 2022 California Association of Public Hospitals and Health Systems (CAPH) Quality Leaders Award (QLA) in the category of health equity. Every year, CAPH showcases the most impressive initiatives that improve and advance high-quality, equitable health care among member systems.

Health equity is the state in which everyone has a fair and just opportunity to attain their highest level of health. This year’s award recognizes UC San Diego Health for forward thinking in establishing same-day infusion treatment protocols for individualized pain control for patients with sickle cell disease, a population of patients that often face racial discrimination.

“On behalf of the medical team at UC San Diego Health, I am thrilled to accept this award from CAPH. The award recognizes our universal commitment to caring for patients in a safe, timely and equitable manner, regardless of race or ethnicity,” said Srila Gopal, MBBS, hematologist and medical director of the adult sickle cell program at UC San Diego Health. “In this case, we developed a novel approach to caring for patients with sickle cell disease in medical crisis.”

“Sickle cell disease is a disease of significant health care disparities,” said Patty Maysent, CEO, UC San Diego Health. “Our team took the initiative to investigate the issue and to develop an effective telemedicine strategy and program to help patients receive patient-centered care in a timely fashion.”

During the pandemic, UC San Diego Health launched a same-day infusion program for patients with sickle cell disease in extreme pain. The outpatient program is an alternative to the emergency department.

“Patients are typically seen on the same day of reporting symptoms and as soon as an infusion slot becomes available,” said Gopal.

Sickle cell disease is a devastating inherited blood disorder that disproportionally affects individuals of African and Hispanic descent. Patients with the condition periodically experience excruciating pain when unhealthy red blood cells block blood flow through tiny blood vessels to the chest, abdomen and joints. Over time, the lack of oxygen to organs and tissues causes permanent damage.

The condition affects approximately 100,000 Americans and occurs in approximately 1 out of every 365 Black or African-American births. The estimated life expectancy for adult patients in California is 42 to 47 years old, a decade less than the rest of the country.

“For patients in sickle cell crisis, intense pain can be accompanied by anemia and infections leading to tissue damage and strokes,” said Gopal. “Unfortunately, these patients often face bias and discrimination from providers who incorrectly assume that requests for pain management are a ‘drug seeking’ behavior for opioids rather than a legitimate health emergency.”

Episodes of pain for these patients represent a “vaso-occlusive crisis” that must be addressed without delay to protect vital organs. Treatment may include supportive care including fluids, pain medication and occasionally antibiotics and blood transfusions.

“What we have seen as a result of implementation is that our emergency room unitization has significantly decreased,” said Gopal. “The program is an effective way to see patients in an outpatient setting while facilitating compassionate care.”

The telehealth program enables easy communication between medical providers and patients, allowing the medical team to attend to patient needs in a timely fashion, despite pressures of the pandemic. Care is coordinated among infusion and outpatient sickle cell teams, including nurse case managers, physicians, advanced care providers and schedulers.

Gopal and team hope to expand the program to further increase the number of patients treated, offer treatment after-hours and also collaborate with the emergency department in redirecting patients to the infusion center for treatment.

Adults with sickle cell disease have limited access to care in California. Recognizing this need, UC San Diego Health established a comprehensive adult sickle cell program and is part of the Networking California for Sickle Cell Care program.

No Comments Yet

Leave a Reply

Your email address will not be published.